Annual Net Income
-$42.20 M
+$2.62 M+5.85%
31 December 2023
Summary:
Kala Pharmaceuticals annual net profit is currently -$42.20 million, with the most recent change of +$2.62 million (+5.85%) on 31 December 2023. During the last 3 years, it has risen by +$62.13 million (+59.55%). KALA annual net income is now -152.96% below its all-time high of -$16.68 million, reached on 31 December 2015.KALA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$8.95 M
+$629.00 K+6.57%
30 September 2024
Summary:
Kala Pharmaceuticals quarterly net profit is currently -$8.95 million, with the most recent change of +$629.00 thousand (+6.57%) on 30 September 2024. Over the past year, it has dropped by -$246.00 thousand (-2.83%). KALA quarterly net income is now -130.78% below its all-time high of $29.07 million, reached on 30 September 2022.KALA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$38.96 M
-$246.00 K-0.64%
30 September 2024
Summary:
Kala Pharmaceuticals TTM net profit is currently -$38.96 million, with the most recent change of -$246.00 thousand (-0.64%) on 30 September 2024. Over the past year, it has increased by +$7.45 million (+16.06%). KALA TTM net income is now -641.87% below its all-time high of -$5.25 million, reached on 31 March 2016.KALA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALA Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.8% | -2.8% | +16.1% |
| 3 y3 years | +59.5% | +68.2% | +69.1% |
| 5 y5 years | +36.8% | +61.4% | +60.1% |
KALA Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +70.4% | -130.8% | +81.2% | -351.1% | +73.2% |
| 5 y | 5 years | at high | +70.4% | -130.8% | +81.2% | -351.1% | +73.2% |
| alltime | all time | -153.0% | +70.4% | -130.8% | +81.2% | -641.9% | +73.2% |
Kala Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.95 M(-6.6%) | -$38.96 M(+0.6%) |
| June 2024 | - | -$9.58 M(-18.9%) | -$38.72 M(-2.1%) |
| Mar 2024 | - | -$11.81 M(+36.9%) | -$39.55 M(-6.3%) |
| Dec 2023 | -$42.20 M(-5.9%) | -$8.63 M(-0.9%) | -$42.20 M(-9.1%) |
| Sept 2023 | - | -$8.70 M(-16.4%) | -$46.41 M(+437.3%) |
| June 2023 | - | -$10.41 M(-28.0%) | -$8.64 M(-67.2%) |
| Mar 2023 | - | -$14.46 M(+12.6%) | -$26.34 M(-41.2%) |
| Dec 2022 | -$44.82 M(-68.6%) | -$12.84 M(-144.2%) | -$44.82 M(-43.7%) |
| Sept 2022 | - | $29.07 M(-203.4%) | -$79.55 M(-41.8%) |
| June 2022 | - | -$28.11 M(-14.7%) | -$136.75 M(-5.8%) |
| Mar 2022 | - | -$32.94 M(-30.7%) | -$145.13 M(+1.8%) |
| Dec 2021 | -$142.60 M(+36.7%) | -$47.57 M(+69.1%) | -$142.60 M(+13.0%) |
| Sept 2021 | - | -$28.13 M(-22.9%) | -$126.15 M(+0.1%) |
| June 2021 | - | -$36.50 M(+20.0%) | -$125.97 M(+11.7%) |
| Mar 2021 | - | -$30.41 M(-2.2%) | -$112.78 M(+8.1%) |
| Dec 2020 | -$104.33 M | -$31.11 M(+11.3%) | -$104.33 M(+9.6%) |
| Sept 2020 | - | -$27.95 M(+19.9%) | -$95.17 M(+5.3%) |
| June 2020 | - | -$23.31 M(+6.2%) | -$90.40 M(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$21.95 M(-0.0%) | -$90.91 M(-3.6%) |
| Dec 2019 | -$94.35 M(+41.4%) | -$21.96 M(-5.3%) | -$94.35 M(-3.3%) |
| Sept 2019 | - | -$23.18 M(-2.7%) | -$97.61 M(+8.4%) |
| June 2019 | - | -$23.82 M(-6.2%) | -$90.03 M(+11.4%) |
| Mar 2019 | - | -$25.39 M(+0.7%) | -$80.83 M(+21.1%) |
| Dec 2018 | -$66.74 M(+58.1%) | -$25.22 M(+61.6%) | -$66.74 M(+26.4%) |
| Sept 2018 | - | -$15.60 M(+6.7%) | -$52.81 M(+11.5%) |
| June 2018 | - | -$14.62 M(+29.4%) | -$47.38 M(+8.3%) |
| Mar 2018 | - | -$11.30 M(+0.1%) | -$43.75 M(+3.6%) |
| Dec 2017 | -$42.21 M(+27.3%) | -$11.29 M(+11.0%) | -$42.21 M(+7.4%) |
| Sept 2017 | - | -$10.18 M(-7.4%) | -$39.31 M(+1.3%) |
| June 2017 | - | -$10.99 M(+12.6%) | -$38.81 M(+3.0%) |
| Mar 2017 | - | -$9.76 M(+16.2%) | -$37.67 M(+13.6%) |
| Dec 2016 | -$33.17 M(+98.8%) | -$8.39 M(-13.2%) | -$33.17 M(+33.9%) |
| Sept 2016 | - | -$9.67 M(-1.9%) | -$24.77 M(+64.0%) |
| June 2016 | - | -$9.85 M(+87.6%) | -$15.11 M(+187.6%) |
| Mar 2016 | - | -$5.25 M | -$5.25 M |
| Dec 2015 | -$16.68 M | - | - |
FAQ
- What is Kala Pharmaceuticals annual net profit?
- What is the all time high annual net income for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals annual net income year-on-year change?
- What is Kala Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals quarterly net income year-on-year change?
- What is Kala Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals TTM net income year-on-year change?
What is Kala Pharmaceuticals annual net profit?
The current annual net income of KALA is -$42.20 M
What is the all time high annual net income for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high annual net profit is -$16.68 M
What is Kala Pharmaceuticals annual net income year-on-year change?
Over the past year, KALA annual net profit has changed by +$2.62 M (+5.85%)
What is Kala Pharmaceuticals quarterly net profit?
The current quarterly net income of KALA is -$8.95 M
What is the all time high quarterly net income for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high quarterly net profit is $29.07 M
What is Kala Pharmaceuticals quarterly net income year-on-year change?
Over the past year, KALA quarterly net profit has changed by -$246.00 K (-2.83%)
What is Kala Pharmaceuticals TTM net profit?
The current TTM net income of KALA is -$38.96 M
What is the all time high TTM net income for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high TTM net profit is -$5.25 M
What is Kala Pharmaceuticals TTM net income year-on-year change?
Over the past year, KALA TTM net profit has changed by +$7.45 M (+16.06%)